Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics. Neurology 2012 Sep 25;79(13 Suppl 1):S68-76
Date
10/04/2012Pubmed ID
23008416DOI
10.1212/WNL.0b013e3182695871Scopus ID
2-s2.0-84867512505 (requires institutional sign-in at Scopus site) 14 CitationsAbstract
Understanding of the pharmacology of thrombolytics, anticoagulants, and antiplatelets is critical to performing safe and effective endovascular therapy for acute ischemic therapy. This is a basic review of the clinical pharmacologic data on the anticoagulants, antiplatelets, and fibrinolytic agents most commonly used in the treatment of stroke and in the neurointerventional suite.
Author List
Cheng-Ching E, Samaniego EA, Naravetla BR, Zaidat OO, Hussain MSMESH terms used to index this publication - Major topics in bold
AnimalsAnticoagulants
Blood Platelets
Fibrinolytic Agents
Humans
Platelet Aggregation Inhibitors
Stroke
Thrombolytic Therapy